Cystitis News and Research

Latest Cystitis News and Research

Multiple sclerosis drug can beat obstinate bacteria

Encountering bacteria with innocent names such as Pseudomonas aeruginosa and Enterobacteriaceae can lead to hospitalization and - in a worst-case scenario - can also be life-threatening. The bacteria, which cause infections such as pneumonia, frequently develop multi-resistance towards classic antibiotics.

22 Nov 2017

Researchers develop simple urine-based test for rapid and accurate detection of Zika virus

There is no vaccine. No medication. And, no quick, reliable test for Zika virus … until now. Babies born with the virus often have lifelong, devastating birth defects.

15 May 2017

Researchers highlight need to ensure universal access to old antibiotics

Antibiotics used to treat a variety of common bacterial infections are becoming more difficult to access, mostly because the drugs are less profitable for manufacturers to produce and market.

15 May 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

SLU scientist examines potential biomarkers for pain linked to debilitating health conditions

With new funding from The Mayday Fund, a Saint Louis University researcher will leverage her discovery of a pain pathway to determine if either of two key molecules can be used as biomarkers for pain associated with four debilitating health conditions: chemotherapy-induced peripheral neuropathy, endometriosis, interstitial cystitis and vulvodynia.

16 Feb 2017

Researchers show how spinal cord injury causes profound changes in gut microbiota

The community of bacteria that live in our intestines, also called the "gut microbiome," is important to normal intestinal function.

18 Oct 2016

Researchers examine link between leisure-time physical activity and bacterial infections

The risk of viral infections is known to be affected by physical activity, but little information is available regarding the more serious infections caused by bacteria.

23 Sep 2016

New discovery could lead to effective treatment methods for cystitis

Every year, millions of people are treated for cystitis, but despite its prevalence, the disease is still a scientific mystery.

30 Aug 2016

First clinical trial to study use of Chinese Herbal Medicines in treating RUTIs

Researchers at the University of Southampton are to study the use of Chinese Herbal Medicines in treating recurrent urinary tract infections (RUTIs), in the first clinical trial of its kind in the UK.

25 May 2016

Research shows how recreational ketamine abuse harms the bladder

Research conducted by scientists at the University of York has revealed how recreational ketamine abuse damages the bladder

21 Mar 2016

Researchers discover how E. coli bacteria adhere to urinary tract

Almost every second woman suffers from a bladder infection at some point in her life. Also men are affected by cystitis, though less frequently. In eighty percent of the cases, it is caused by the intestinal bacterium E. coli.

8 Mar 2016

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Amgen and UCB today announced top-line results from the Phase 3 placebo-controlled FRActure study in postmenopausal woMen with ostEoporosis (FRAME).

22 Feb 2016

New ICN Food List app can help people struggling with urinary tract food sensitivity

If you're scared to drink a cup of coffee out of fear that you'll spend the day in the restroom, you're not alone. Mild urinary frequency and urgency are common but for patients with urinary disorders, these same foods can provoke days of pain and discomfort. A new android application, the ICN Food List, seeks to change that by giving patients a reference guide that they can easily use while shopping and eating out at restaurants.

15 Dec 2015

New NICE-accredited guidelines on prevention and control of MDRGNB available online

Gram-negative bacteria (MDRGNB) include common types such as E. coli that all of us carry in our bowels. When these bacteria get into other parts of the body they can cause infections, including common infections such as cystitis or urinary tract infections. The bacteria can also be readily spread from person to person. Multi-drug-resistant strains are resistant to most, or all, of the common antibiotics that we use to treat infections.

18 Nov 2015

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced that it has entered into a license agreement with Advanced Dosage Forms, Inc. to expand Imprimis' proprietary ophthalmic injectable and combination topical compounded formulations into Canada. Under the agreement, the licensee has the rights to formulate, market and sell these formulations across Canada.

12 Aug 2015

SUNY Downstate Medical Center researchers identify ALPIM syndrome as new spectrum disorder

The relationship between mental and physical health is well established. But when mental and physical illnesses co-occur, patients' accounts of physical illness are sometimes arbitrarily discredited or dismissed by physicians.

10 Jul 2015

Study shows 28% decline in prostate cancer diagnoses following USPSTF recommendation against PSA testing

A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S. declined 28 percent in the year following the draft recommendation from the United States Preventive Services Task Force against routine PSA screening for men.

19 Jun 2015

Botulinum toxin A effective for treating bladder disorders

While Botulinum toxin A (BTX-A), known to the public as Botox, is commonly associated with smoothing wrinkles for a more youthful appearance, three studies presented at the 110th Annual Scientific Meeting of the American Urological Association are proving BTX-A to be more than just a cosmetic solution.

17 May 2015

Imprimis has exclusive US commercial rights for patented Hep-Lido-A formulation

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced it now has the exclusive US commercial rights to the patented compounded alkalinized lidocaine and heparin formulation ("Hep-Lido-A" or "HLA") for the treatment of interstitial cystitis ("IC"), commonly referred to as painful bladder syndrome ("PBS").

28 Apr 2015

Research findings lay groundwork for improving treatment assessment for men with prostate cancer

UCLA researchers have found that radiation therapy is the most common treatment for men with prostate cancer regardless of the aggressiveness of the tumor, risk to the patient and overall patient prognosis. These findings lay the groundwork for improved treatment assessment by physicians and to better inform men fighting the disease.

20 Feb 2015

Cystitis News and Research

Latest Cystitis News and Research

Multiple sclerosis drug can beat obstinate bacteria

Researchers develop simple urine-based test for rapid and accurate detection of Zika virus

Researchers highlight need to ensure universal access to old antibiotics

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

SLU scientist examines potential biomarkers for pain linked to debilitating health conditions

Researchers show how spinal cord injury causes profound changes in gut microbiota

Researchers examine link between leisure-time physical activity and bacterial infections

New discovery could lead to effective treatment methods for cystitis

First clinical trial to study use of Chinese Herbal Medicines in treating RUTIs

Research shows how recreational ketamine abuse harms the bladder

Researchers discover how E. coli bacteria adhere to urinary tract

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

New ICN Food List app can help people struggling with urinary tract food sensitivity

New NICE-accredited guidelines on prevention and control of MDRGNB available online

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

SUNY Downstate Medical Center researchers identify ALPIM syndrome as new spectrum disorder

Study shows 28% decline in prostate cancer diagnoses following USPSTF recommendation against PSA testing

Botulinum toxin A effective for treating bladder disorders

Imprimis has exclusive US commercial rights for patented Hep-Lido-A formulation

Research findings lay groundwork for improving treatment assessment for men with prostate cancer

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Cystitis News and Research

Latest Cystitis News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in